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Leprosy is a chronic infectious disease caused by Mycobacterium leprae. The disease more 
frequently affects the nasal mucosa and can occur independently of its clinical form or even before 
lesions on the skin or on other parts of the body. It is necessary to employ epidemiological surveillance 
of household contacts with new leprosy cases for early disease diagnosis. 
Aim: identify specific and early leprosy lesions through endoscopic, baciloscopy, histopathology 
exams, and real time polymerase chain reaction of the nasal cavity mucosa on household and 
peridomiciliary contacts with positive serology for the phenolic glycolipid 1 antigen. 
Methodology: Between 2003 at 2006 there was a prospective cross-sectional clinical study with 31 
contacts with patients with leprosy with positive serology against PGL-1, 05 negative controls and 
01 positive control. 
Results: Between seropositive contacts, real-time PCR was positive for M. leprae DNA in 06 (19.35%) 
of them and the higher number of genome copies were found in contacts who became sick. 
Conclusion: Nasal mucosa tests alone did not enable the early diagnosis of Leprosy. However, 
through the combination of various methods, tests on the contacts can help identify subclinical 
infection and monitor the contacts that could be responsible for spreading the disease.
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INTRODUCTION
Rabello classified leprosy as a polar disease with 
two forms (tuberculoid leprosy or TT, and lepromatous le-
prosy or LL) based on the bodily response to this infection 
starting with an initial indeterminate form (indeterminate 
leprosy or IL). New clinical forms - borderline forms - 
were added to this classification in the VI International 
Leprosy Conference of 1953 in Madrid. These new di-
morphic forms were attributed to patients that progressed 
from IL to uncharacteristic clinical presentations of polar 
TT (paucibacillary with high cellular immune response) 
and LL (multibacillary and low cellular immune response).
After the introduction of polychemotherapy (PCT/
WHO) in the 1980s, new diagnostic tools for an early 
diagnosis of leprosy have been sought. The ability to 
identify groups at an increased risk in highly endemic 
areas in and out of households, together with BCG vac-
cination of contacts, are measures developed in Brazil to 
help decrease the multibacillary forms of this disease. The 
efficacy of these measures, however, has been compromi-
sed by several operating issues that have resulted in high 
detection coefficients in the majority of Brazilian states.
Disease transmission has been debated for year; 
the upper airways, in particular the nose, appear to be 
the main entry and transmission route for Mycobacterium 
leprae. It is thought that 95% of LL patients will have an 
early involvement of the nose. There are specific histo-
pathological changes in the mucosa even without visible 
lesions.1 There are many mucus-producing cells, edema, 
and increased vascularization of the plasmocyte and 
lymphocyte-infiltrated submucosa in the bacillary invasion 
phase of LL patients. This significant amount of mucus 
explains the typical nasal block and rhinorrhea in this 
initial stage. A proliferation phase ensues, in which these 
findings are exacerbated, resulting in a granulous aspect 
of the mucosa; at this point, macrophages predominate in 
the inflammatory infiltrate. In the next stage the mucosa 
becomes ulcerated and damaged; inflammation consists 
of macrophages and numerous bacilli, lymphocytes and 
plasmacytes. In the final phase - resolution and fibrosis 
- bacilli are rare and fibrosis is intense.2
The nasal epithelium is ciliated cylindrical pseu-
dostratified with goblet cells, and rarely remains normal 
because of multiple insults. Such insulting factors include: 
extreme temperatures, infection, pollution, and trauma. 
This continuous aggression decreases the number of 
cilia on which air interacts, and increases the number of 
goblet and inflammatory cells. The progression of squa-
mous metaplasia in this context starts in childhood; it is 
a normal phenomenon, a protective response to external 
factors. It is often seen in allergic rhinopathy.3
Histopathology is extremely valuable for diagno-
sing and classifying the clinical forms of leprosy, espe-
cially in indeterminate cases; this approach may show 
early on to which polar type (tuberculoid or lepromatous) 
the disease will progress. Biopsies should be preserved in 
10% formaldehyde or Millonig (buffered formaldehyde) 
and hematoxylin-eosin, Ziehl-Wade-Klingmuller or Fite 
Faraco stained. 
Among the new support tools for an early diagno-
sis and prediction of these groups there is the serology 
test that detects antibodies against the specific phenolic 
glycolipid antigen 1 (PGL-1) of M. leprae. The PGL-1 is 
specific to this bacillus and comprises about 2% of the 
total bacterial mass; it is found in tissues, circulating 
blood and urine of multibacillary patients. This test has 
been used for diagnosis worldwide,4,5,6 and positivity is 
proportional with the bacillary load; increased exposure 
to bacilli relates with a higher test positivity, ranging from 
1+ (low bacillary load) to 4+ (high bacillary load). The 
DNA-amplification method using the polymerase chain 
reaction (PCR) technique appears to be more specific 
and sensitive for detecting bacilli in the nasal mucosa.7-18 
Several cohort studies,9,10,14-17 based on serum positivity 
(anti-PGL-1) and PCR investigation of bacilli in the nasal 
mucosa, have shown persistent subclinical infection, 
especially in highly endemic areas.
These numbers guided an endoscopic study of the 
nasal cavity mucosa for investigating subclinical infection 
in serum positive contacts in an urban area of metropo-
litan Rio de Janeiro, the Duque de Caxias municipality. 
At the beginning of the study in 2003, the incidence and 
the prevalence of leprosy were respectively 5.04 and 
7.29 per 10 thousand inhabitants in the 2nd district - the 
study micro area. A high endemic rate is evidenced by 
the fact that 11% of new cases were subjects aged below 
15 years, which reflects active and recent transmission of 
this disease, as shown in several studies.19-22 In 2003 there 
was a high rate of new cases with deformity, especially 
in the 1st - and most populated - district (10.7%), 75.7% 
of the cases that were evaluated.
METHOD
A cross-sectional study was carried out from 2003 
to 2006 of 31 contacts of leprosy patients that were 
positive for PGL-1 (out of 1886 contacts that comprised 
the total sample in the serological investigation),23 and 6 
controls, of which one was positive and 5 were negative. 
Contacts and controls underwent nasal endoscopy, nasal 
mucosa smears, and lower right turbinate biopsy for acid-
fast bacilli (AFB) testing, histopathology and real-time 
polymerase chain reaction (RT-PCR). A new data base was 
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built (using SPSS for Windows) containing the following 
data: sex, age, result of anti-PGL-1, the clinical form of 
the index case (MB-multibacillary or PB-paucibacillary), 
the type of relationship (relatives or social relations) with 
the index case, the type of contact (household or peri-
domiciliary) with the index case, the type of exposure 
(daily, weekly or every two weeks) with the index case, 
otorhinolaryngological complaints, nasal endoscopy, AFB, 
histopathology, and RT-PCR. 
The study project was approved - see MEMO-no. 
146/03 and MEMO-no. 0015.0.009.000-04. After accepting 
and signing the free informed consent form, positive test 
contacts aged over 15 years underwent a clinical otorhi-
nolaryngological investigation; all received care according 
to bio-safety guidelines. 
RESULTS
Table 1. Serology and sex, age, index case classifi-
cation, type of relation, type of contact, type of exposure 
to the index case, and RT-PCR; the confidence interval 
(CI) was 95%.
Nasal endoscopy
Figure 5. LEPROUS RHINITIS - Nasal endoscopy 
of a positive control: typical nasal mucosa in leprous 
rhinitis showing diffuse infiltration of the mucosa, dry 
mucosa, superficial ulcers, blood crusts, ectasia, and 
areas of bleeding.
Histology
Semiquantitative analysis of histopathology findin-
gs in contacts was carried out; these were not specific for 
leprosy, and were classified as allergic rhinitis of varying 
intensity. Histopathology was carried out of the positive 
control (leprous rhinitis). 
Slides
Illustration 1: WADE-positive control / leprous 
rhinitis
Illustration 2: RCA/ HE (contact number 19, who 
became ill)
Illustration 3: RCM/HE
Illustration 4: RCS / HE
Table 1. Relation of serology with sex, age, classification of the index case, type of family relation, type of contact with the index case, and RT-
PCR, with a 95% confidence interval (CI).
Variables
2+ (n = 24) 3+ (n = 6) 4+ (n = 1) Total p
nº % nº % nº % %
male 12 70,6 5 29,4   100 0,182
female 12 85,7 1 7,1 1 7,1 100 0,182
> 32 9 64,3 4 28,6 1 7,1 100 0,234
< 32 15 88,2 2 11,8   100 0,234
 CI-MB 18 75 5 20,8 1 4,2 100 0,782
CI-PB 6 85,7 1 14,3   100 0,782
household 16 66,7 1 16,7 1 100 58,1 0,059
peri-domiciliary 8 33,3 5 83,3   41,9 0,059
daily 18 75 5 20,8 1 4,2 100 0,197
+1x /week   1 100   100 0,197
 1x /week 6 100     100 0,197
1st degree 11 91,7   1 8,3 100 0,069
2nd degree 7 58,3 5 41,7   100 0,069
3rd degree 3 75,0 1 25   100 0,069
4th degree 3 100     100 0,069
RT-PCR pos. 5 83,3   1 16,7 100 0,060
 RT-PCR neg. 19 76,0 6 24   100 0,060
Key: n = total; > 32 - age over 32 years; < 32 - age below 32 years; IC = index case of contact; 1st degree relative = parents, children, siblings; 
2nd degree relatives = uncles/aunts, cousins, grandparents, grandchildren, nephews/nieces; 3rd degree relatives = spouse, son-in-law, daughter-
in-law, stepfather/stepmother, stepchildren; 4th degree relative = friend, boy/girlfriend, tenants; RT-PCR pos. = positive real time PCR; RT-PCR 
neg. = negative real time PCR; p= p value.
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Figure 1. Slide at 1000x magnification, WADE stained - leprous rhinitis 
with vacuolated macrophages and bacilli (in red) in clumps.
Figure 2. Acute over chronic rhinitis - slide at 1000x magnification, 
hematoxylin-eosin stained - slide showing eosinophils (binucleated 
cell in the center)
Figure 3. Moderate chronic rhinitis - slide at 400x magnification, 
hematoxylin-eosin stained - slide showing squamous metaplasia (well 
defined darker pink area on the surface)
Figure 4. Severe chronic rhinitis - slide at 400x, hematoxylin-eosin 
stained - slide shows an intense inflammatory infiltrate with areas of 
bleeding
Illustration 6: LEPROUS RHINITIS / HE
Illustration 7: RCL / HE 
Results of laboratory tests in this study
There were 6 contacts with positive serology and 
positive DNA amplification (RT-PCR). The index cases 
in 4 of these contacts were multibacillary patients; in 
another 2 contacts, the index cases were paucibacillary. 
Five among the 6 contacts had positive 2+ serum levels 
and one had a 4+ serum level. The age ranged from 16 
to 70 years; there were 4 females and 2 males. 
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series - 1886 contacts - not only because negative, doub-
tful and positive 1+ anti-PGL-1 cases were excluded, but 
also because subjects raised several hurdles: resistance 
from asymptomatic individuals, distance and transpor-
tation difficulties, subjects of lower social and econo-
mic status, and the possibility of undergoing invasive 
procedures such as a nasal biopsy. Thus, for safety and 
operational aspects, the study focused on subjects aged 
over 15 years. The serological inquiry revealed that 31% 
of positive contacts were aged less than 15 years, and 
were therefore excluded. 
Figure 5. Leprous rhinitis - nasal endoscopy of the positive control 
showing a diffuse infiltration of the mucosa, blood crusts and dry 
mucosa to the left.
Figure 6. Leprous rhinitis - slide at 200x magnification, hematoxylin-
eosin stained - dense inflammation (cells with purple nuclei) and many 
vacuolated macrophages.
Figure 7. Mild chronic rhinitis - slide at 200x magnification, hemato-
xylin-eosin stained - slide showing a mild inflammatory infiltrate (cells 
with purple nuclei and clear pink tissue) and gland dilatation (central 
nodular aspect).
Frame 1. Results of laboratory tests of leprosy contacts. 
N male female CI -PB CI-MB PGL1 2+ PGL1 3+ PGL1 4+ BAAR PCR-RT RCL  RCA RCM RCI
31 15 16 07 24 24 06 01 0 06 09 09 09 03
key: N (total no. of contacts); IC-PB- number of paucibacillary index cases of contact; IC-MB - number of multibacillary index cases of contact, 
PGL -1 - number of contacts with positive serology (Ml Flow); EX. AFB MN - bacilloscopic exam of the nasal mucosa; Real time PCR - number of 
contacts tested positive, Histopathology: RCL - mild chronic rhinitis; RCM - moderate chronic rhinitis; RCI - severe chronic rhinitis; RCA - acute 
chronic rhinitis. 
DISCUSSION
The study sample is small compared to the whole 
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It is important for epidemiological purposes to 
investigate contacts outside households. It is possible to 
identify transmission sources and subclinical infection 
in peri-domiciliary contacts, and to understand the true 
role of the nasal mucosa in this context. The percentages 
among serum positive cases were 58.1% for household 
cases and 41.9% for peri-domiciliary cases. Most of the 
latter cases were 3+ serum positive (83.3%), and most of 
the former cases were 2+ serum positive (66.7%). Coexis-
ting in a common area with index cases is habitual in the 
Duque de Caxias municipality, which thus characterizes 
the concept of a peri-domiciliary space. Daily closeness 
to 1st and 2nd degree relatives was more evident in 2+ 
serum positive cases; for 3+ contacts the most common 
family relation was 2nd degree relatives (Table 1). The 
possibility of subclinical infection is raised based on the 
results, as extrapolation of household limits was signi-
ficant in the serological context (p = 0.059 / Table 1).
There were no significant percentage correlations 
between contacts with positive sera and the clinical form 
of the index case; nevertheless, there was a tendency for 
a higher rate of mutibacillary index cases. The index case 
clinical form was unrelated to serum positivity of contacts; 
this index case was not the primary case or the source 
of transmission for the secondary case.23
A comparison of serology (anti-PGL-1) and RT-
PCR results showed that the percentages are close to 
statistical significance (p=0.060/Table 1). This underli-
nes the importance of exposure to bacilli and its effect 
on serology, even in contacts with lower serum levels. 
However, the clinical form of the index case was un-
related with PCR positivity. Although the multibacillary 
clinical form predominated, there was no statistically 
significant difference compared with contacts exposed 
to the paucibacillary clinical form. This result underlines 
the importance of including the paucibacillary form as a 
disease transmission source. Van Beers12 and Moet24 have 
suggested that contacts of paucibacillary patients appear 
to be at a higher risk of becoming infected compared to 
the general population. 
In the context of transmission, we found 7 contacts 
of paucibacillary index cases. Of these, 2 had positive 
serology and RT-PCR, and 5 had positive serology only. 
Of the former 2, serology increased from 2+ to 4+ in 
one patient after investigation of the mucosa, and the 
patient eventually became ill; the second patient remai-
ned unaltered. The contact that became a case had no 
history of any contact with multibacillary cases; thus, 
there are doubts about the true source of transmission. 
This finding is important in the epidemiological chain of 
events in the disease when taking into account multiba-
cillary patients as the only disease transmission source. 
As in most studies,9,10, 12,14-17,25-28, there were 24 contacts of 
multibacillary index cases. 
Note that the detection of anti-PGL-1 antibodies 
may support disease classification because it expresses 
bacillary load, supports the diagnosis and may help 
identify infected contacts.5,6,29 Serology, however, do not 
necessarily mean infection; in most people, it expresses 
resistance to M. leprae, and if such individuals become 
Frame 2. Results of laboratory tests of the positive control.
N SEX AGE CI EX. BAAR MN Anti-PGL-1 PCR HISTOPATHOLOGY
1 M 26 NC NEG 2+ POS
Vacuolated macrophages with numerous bacilli in clumps and intense 
inflammation
Key: male patient, 26 years, negative nasal mucosa AFB test, unknown index case (IC), 2+ anti-PGL-1, positive PCR, and histopathology of 
leprous rhinitis.
Frame 3. Results of contacts with positive RT-PCR and contact that became ill.
Age CI Anti-PGL-1 PCR Ct Log of mass mass Genome copies
70 MB 4+ Pos 35,27 0,782178218 0,165128 41,28210089
40 PB 2+ Pos 35,62 0,897689769 0,126564 31,64100284
37 MB 2+ Pos 35,34 0,805280528 0,156574 39,14348425
30 PB 2+ Pos 28 1,6117161716 41,41539 10353,84657
21 MB 2+ Pos 35,02 0,699669967 0,199678 49,91947873
16 MB 2+ Pos 35,11 0,729372937 0,186478 46,61944204
Key: Ct - number of cycles in RT-PCR; Log of mass - DNA mass expressed as log; mass 
DNA mass of M. leprae and number of genome copies. - contact that became ill: 
Contact with the PB index case, 2+ PGL-1, with larger mass, more genome copies and lower Ct.
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ill, they have a low bacillary load (paucibacillary) and 
therefore low anti-PGL-1 IgM immunoglobulin levels.4,29-31
It is assumed that contacts have transient subcli-
nical infection - with or without the disease progressing 
- as a consequence of the nasal discharge of bacilli-
ferous patients. Thus, it has been suggested that the 
nasal mucosa is the probable site of an initial immune 
response.9,10,13,15,17,26,32-39 Some authors have postulated 
that leprosy patients as well as healthy contacts may be 
asymptomatic carriers of M. leprae in their nasal mucosa. 
Note that most contacts reported non-specific com-
plaints reminiscent of allergic rhinopathy, such as nasal 
block (35.5%), pruritis (25.8%), rhinorrhea (29%) and 
sneezing (9.7%). Added to these complaints are humid 
and poorly ventilated households, and dusty and unpaved 
roads, favorable environments for M. leprae. It sits on the 
nasal mucosa and during the initial phase of the disease 
may cause nasal block and rhinorrhea, which are often 
mistaken for a common cold. Still, no association between 
the presence of otorhinolaryngological complaints and 
positive RT-PCR tests has been found (p=0.318).
Constant aggression from the environment may 
explain the histology of contacts. In the contact that 
became a disease case a year after the nasal mucosa test 
(Frame 3), the nasal mucosa histology led to a classifi-
cation of acute episodes in chronic allergic rhinitis. This 
finding could support the hypothesis of leprous rhinitis 
occurring at the initial phase when bacilli are deposited 
on the nasal mucosa.2 At this point, classical symptoms - 
nasal block and rhinorrhea - would ensue. This analysis 
is semi-quantitative, and superior results could be gained 
with morphometric histological studies (quantitative) of 
the mucosa of contacts; this requires further study. 
New techniques, such as RT-PCR, have improved 
the detection of M. leprae and supported traditional 
methods for diagnosing leprosy (bacilloscopy and histo-
pathology); these are major advances compared to the 
clinical diagnosis only. Quantitative tests, which are more 
precise, may be carried out. As leprosy may be related 
to genetic and environmental factors, and exposure to 
bacilli, positive PCR testing in blood and nasal secretion 
samples of contacts does not necessarily characterize ill-
ness.16 Nasal mucosa biopsies and DNA amplification by 
RT-PCR revealed a 19.35% positivity rate for the presence 
of M. leprae among the sample contacts of this study. 
A comparison of our results with other studies in which 
the PCR technique was used (9.8%;9 7.8%;10 12.8%;14 
4.6%;15 1.7%;16 and 10.1%17), we found that the tested 
specimens varied (mucus swab or mucosa) as did PCR tes-
ting (conventional method in agarose gel plates), which 
may affect the results. Our study sample was smaller (n = 
31), which may have increased the positivity rate among 
seropositive contacts. Still, the percentage (19.35%) was 
due to mucosa biopsy samples and RT-PCR, which is 
highly specific and sensitive, and thus adopted as the 
standard at the laboratory where these samples were 
analyzed. Further studies on this topic are recommended, 
with larger samples for improved analyses. 
Absence of positivity in negative controls was 
evidence of the specificity and sensitivity of RT-PCR in 
positive contacts. The PCR identifies M. leprae and also 
makes it possible to quantify the DNA to help clarify the 
diagnosis of suspected cases. The contact that became 
ill in the year after the nasal mucosa test had a large 
number of M. leprae genome copies, and eventually se-
rum conversion progressed from 2+ to 4+. Ramaprasad35 
has suggested that such serological changes occur after 
infection of the nasal mucosa (PCR +) and eventual sys-
temic dissemination and an immune response. Based on 
DNA quantification of contacts at a higher risk in studies 
with larger sample sizes and longer follow-up, it may be 
possible to establish a disease-indicating value. 
Finding M. leprae in nasal cavities is relatively 
common in highly endemic areas. Nevertheless, PCR 
positivity does not differ between contacts and non-
contacts, as mentioned above. It is thought that bacilli 
do not remain continuously on the nasal mucosa, and 
that most subclinical infections resolve spontaneously, 
never progressing to a disease. New techniques, such 
as serology, and molecular biology, have increased our 
knowledge of the epidemiology of leprosy; there are still 
important gaps in our knowledge of how this disease is 
transmitted. 
CONCLUSION
Nasal mucosa tests alone are insufficient for an ear-
ly diagnosis of leprosy. However, by combining several 
methods and by examining contacts, subclinical infection 
may be identified, and patients at a higher risk - such as 
the contact that became ill - may be monitored. 
No contact in our series had endoscopic or histolo-
gical findings specific to leprosy; neither was the mucosa 
positive for AFB to make an early diagnosis possible.
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